Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Regulatory lnflexibility May Require UniQure To Conduct Sham Surgery
Mar 02 2026
•
By
Joseph Haas
UniQure may need to run a sham surgery-controlled HD trial to satisfy the FDA
(Shutterstock)
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Gene Therapies
More from Advanced Therapies